- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Tenofovir with emtricitabine – July 2017
Tenofovir with emtricitabine: Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg ;Tenofovir Disoproxil Emtricitabine Mylan 300/200®
Last updated
10 November 2017